Maha Katabi's Net Worth
Estimate Recalculated Nov 1, 2024 11:27AM EST
Who is Maha Katabi
Maha Katabi does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vera Therapeutics, Inc., , Aerovate Therapeutics, Inc., Inozyme Pharma, Inc., Bolt Biotherapeutics, Inc., Akouos, Inc., and RayzeBio, Inc..
SEC CIK
Maha Katabi's CIK is 0001720685
Past Insider Trading and Trends
2023 was Maha Katabi's most active year for acquiring shares with 4 total transactions. Maha Katabi's most active month to acquire stocks was the month of April. 2024 was Maha Katabi's most active year for disposing of shares, totalling 1 transactions. Maha Katabi's most active month to dispose stocks was the month of January. 2023 saw Maha Katabi paying a total of $47,496.16 for 53,362 shares, this is the most they've acquired in one year. In 2024 Maha Katabi cashed out on 18,235 shares for a total of $0.00, their largest year based on trade value.
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
